Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-055586

CRESCENT BIOPHARMA, INC. · CBIO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
John L. Magnani
Officer — SVP of Research, CSO · Director
Period of report
Oct 16, 2018
Accepted (ET)
Oct 18, 2018 · 5:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001253689

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Oct 16, 2018S14,200$14.01D86,593D
Common StockF3Oct 17, 2018S7,273$14.00D79,320D
Common StockF2Oct 18, 2018S3,527$14.02D75,793D
Common StockF4holding———4,845IBy GlycoTech Corporation

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses